MELI vs RPID · P/E 43, rev $19.01B vs rev $16.1M
MercadoLibre Inc. (MELI) versus Rapid Micro Biosystems Inc (RPID) — a side-by-side from cached financials, not a winner call.
MercadoLibre Inc. (MELI) is a internet retail company listed on NASDAQ.
Rapid Micro Biosystems Inc (RPID) is a medical devices company listed on NASDAQ.
Latest reported MELI revenue for 2026-06-30 was $19.01B. Net income was $883.0M. MELI currently screens at market cap $82.73B and trailing P/E 43.1.
Latest reported RPID revenue for 2026-06-30 was $16.1M. Net income was -$27.2M. RPID currently screens at market cap $85.7M.
MELI currently screens at market cap $82.73B and trailing P/E 43.1. RPID currently screens at market cap $85.7M.
Not investment advice. Open the MELI and RPID stock pages for the full models.
Not investment advice.